CIK: 0001512848 · Show all filings
Period: Q4 2016 (← Previous) (Next →)
Filing Date: Feb 9, 2017
Total Value ($000): $2,514,984 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | TESARO INC | 10,275,113 | $1,381,797 | 54.9% | $34.30 | — | COM | 881569107 |
| ARDX | ARDELYX INC | 14,083,582 | $199,987 | 8.0% | $12.70 | +11.7% | COM | 039697107 |
| — | DERMIRA INC | 3,506,649 | $106,357 | 4.2% | $15.35 | — | COM | 24983L104 |
| — | EPIZYME INC | 6,260,851 | $75,756 | 3.0% | $24.91 | — | COM | 29428V104 |
| — | SENSEONICS HOLDINGS INC | 26,305,286 | $70,235 | 2.8% | $2.86 | — | COM | 81727U105 |
| — | ACHAOGEN INC | 5,215,125 | $67,901 | 2.7% | $4.67 | — | COM | 004449104 |
| — | GROUPON INC | 20,075,762 | $66,652 | 2.7% | $8.55 | — | COM | 399473107 |
| CRSP | CRISPR THERAPEUTICS AG | 3,220,728 | $65,252 | 2.6% | $18.69 | 0.0% | NAMEN AKT | H17182108 |
| — | RA PHARMACEUTICALS INC | 3,493,636 | $53,068 | 2.1% | $15.19 | — | COM | 74933V108 |
| — | GLYCOMIMETICS INC | 8,584,128 | $52,363 | 2.1% | $16.33 | — | COM | 38000Q102 |
| — | CLOVIS ONCOLOGY INC | 1,139,890 | $50,634 | 2.0% | $66.98 | — | COM | 189464100 |
| — | PROTEOSTASIS THERAPEUTICS INC | 3,556,778 | $43,606 | 1.7% | $10.41 | — | COM | 74373B109 |
| ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | 9,880,999 | $40,018 | 1.6% | $8.13 | — | ADR | 00653A107 |
| LXRX | LEXICON PHARMACEUTICALS INC | 2,382,286 | $32,947 | 1.3% | $12.29 | +30.5% | COM NEW | 528872302 |
| — | CARE COM INC | 3,260,989 | $27,947 | 1.1% | $8.15 | — | COM | 141633107 |
| — | AEROHIVE NETWORKS INC | 4,673,536 | $26,639 | 1.1% | $8.02 | — | COM | 007786106 |
| — | NEVRO CORP | 359,678 | $26,134 | 1.0% | $38.67 | — | COM | 64157F103 |
| — | TREVENA INC | 3,811,691 | $22,413 | 0.9% | $7.47 | — | COM | 89532E109 |
| — | ENDOLOGIX INC | 2,490,204 | $14,244 | 0.6% | $8.36 | — | COM | 29266S106 |
| — | TRACON PHARMACEUTICALS INC | 2,759,217 | $13,520 | 0.5% | $11.16 | — | COM | 89237H100 |
| — | STRONGBRIDGE BIOPHARMA PLC | 4,141,308 | $9,939 | 0.4% | $5.09 | — | SHS USD | G85347105 |
| AUPH | AURINIA PHARMACEUTICALS INC | 4,067,743 | $8,542 | 0.3% | $3.43 | -6.1% | COM | 05156V102 |
| — | CASCADIAN THERAPEUTICS INC | 1,791,666 | $7,722 | 0.3% | $4.31 | — | COM NEW | 14740B606 |
| — | RIGEL PHARMACEUTICALS INC | 3,243,150 | $7,719 | 0.3% | $3.34 | — | COM NEW | 766559603 |
| — | AVEO PHARMACEUTICALS INC | 10,362,694 | $5,596 | 0.2% | $0.96 | — | COM | 053588109 |
| — | MIRNA THERAPEUTICS INC | 2,974,811 | $5,355 | 0.2% | $6.25 | — | COM | 60470J103 |
| — | DASAN ZHONE SOLUTIONS INC | 4,781,290 | $4,704 | 0.2% | $1.14 | — | COM | 23305L107 |
| — | SUNESIS PHARMACEUTICALS INC | 1,298,274 | $4,700 | 0.2% | $4.37 | — | COM PAR | 867328700 |
| — | ARCA BIOPHARMA INC | 1,460,209 | $4,162 | 0.2% | $4.96 | — | COM PAR $.001 | 00211Y407 |
| CSBR | CHAMPIONS ONCOLOGY INC | 1,562,500 | $3,953 | 0.2% | $6.08 | -68.0% | COM NEW | 15870P307 |
| — | ROKA BIOSCIENCE INC | 893,471 | $3,788 | 0.2% | $4.24 | — | COM NEW | 775431208 |
| — | AKARI THERAPEUTICS PLC | 452,167 | $3,183 | 0.1% | $13.49 | — | ADR | 00972G108 |
| — | ARQULE INC | 2,520,316 | $3,176 | 0.1% | $2.32 | — | COM | 04269E107 |
| — | ZOSANO PHARMA CORP | 2,052,809 | $1,601 | 0.1% | $10.11 | — | COM | 98979H103 |
| — | PARATEK PHARMACEUTICALS INC | 66,245 | $1,020 | 0.0% | $38.55 | — | COM | 699374302 |
| — | AGILE THERAPEUTICS INC | 133,488 | $761 | 0.0% | $6.70 | — | COM | 00847L100 |
| — | OREXIGEN THERAPEUTICS INC | 370,900 | $645 | 0.0% | $3.32 | — | COM NEW | 686164302 |
| — | CERECOR INC | 595,435 | $524 | 0.0% | $2.01 | — | COM | 15671L109 |
| — | CATALYST BIOSCIENCES INC | 652,380 | $424 | 0.0% | $4.66 | — | COM | 14888D109 |